Bu-Shu Xu

PD-L1 Expression Is Associated with FOXP3+ Regulatory T-Cell Infiltration of Soft Tissue Sarcoma and Poor Patient Prognosis

Yi Que, Wei Xiao, Yuan-xiang Guan et al. · Journal of Cancer · 2017 · 101 citations · Full text

Life Sciences, Immunology, Oncology +17

Frequent amplification of HDAC genes and efficacy of HDAC inhibitor chidamide and PD-1 blockade combination in soft tissue sarcoma

Yi Que, Xiao-Long Zhang, Xiao-Long Zhang et al. · Journal for ImmunoTherapy of Cancer · 2021 · 94 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Haemoglobin, Neutrophil to Lymphocyte Ratio and Platelet Count Improve Prognosis Prediction of the TNM Staging System in Nasopharyngeal Carcinoma: Development and Validation in 3237 Patients from a Single Institution

Hui Chang, Jin Gao, Bu-Shu Xu et al. · Clinical Oncology · 2013 · 62 citations

Medicine, Hematology, Oncology +9

Phase 1 clinical trial to assess safety and efficacy of NY-ESO-1-specific TCR T cells in HLA-A∗02:01 patients with advanced soft tissue sarcoma

Qiuzhong Pan, Desheng Weng, Jiayong Liu et al. · Cell Reports Medicine · 2023 · 50 citations · Full text

Medicine, Immunology, Oncology +16

Anlotinib as a maintenance treatment for advanced soft tissue sarcoma after first-line chemotherapy (ALTER-S006): a multicentre, open-label, single-arm, phase 2 trial

Bu-Shu Xu, Qiuzhong Pan, Pan Hua et al. · EClinicalMedicine · 2023 · 32 citations · Full text

Medicine, Oncology, Pharmacology +12